Design (Testphase)
Risk & Weakness
Insolvency Radar: Cash Running Low
139
Findings
August 3, 2026
last calculated
Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · showing the 100 strongest hits
The mirror image of the Graham Net-Net shopping list: instead of companies with a bulging current-asset cushion, this scanner finds companies that are running out of cash. Criteria: the operating business is burning cash (operating cash flow over the trailing four quarters is negative in total), and cash plus short-term investments would last less than four quarters at the current burn rate. Unlike score-based early warnings (Altman Z, the Going Concern proxy), this scanner calculates specifically how long the cash will last. Banks and financial services companies are excluded (their cash flow fluctuates for structural reasons and isn't a valid burn rate), as are micro-caps under $20 million in market cap and obvious data outliers. Important: a hit is not a bankruptcy verdict — many of these companies save themselves through a capital raise or credit line, diluting existing shareholders in the process. For portfolio holders, an early-warning system; for bargain hunters, the opposite of a shopping list. Source: fundamental data.
No global trading filters — this strategy checks the entire stock universe purely against its own criteria (mega caps over $50B included).
🔔 Watch scanner
Terms in This Scanner Explained
(18)
- ADR (Average Daily Range)
- The average daily swing of a stock in percent - measured over 10 or 30 trading days (columns "ADR 10D/30D"). An ADR of 5% means: on a normal day the gap between the intraday low and high runs about 5%. Traders look for movement - that is why stocks with an ADR under 1% are filtered out globally. Not to be confused with ADR meaning "American Depositary Receipt" (a US certificate for foreign shares) - here ADR always means the daily swing.
- AI Classification
- Our company-by-company assessment of the AI boom based on SEC filings (the last four quarterly 10-Q reports and two annual 10-K reports): "Sells AI" (AI is a revenue source), "Threatened" (AI is a concrete business risk), "Uses AI" (operational use), or "Neutral" (no material AI exposure). Every classification requires at least two direct quote citations - otherwise the column shows "-". Not a quality judgment or a buy recommendation; the full file is on the stock page, methodology at /stocks/ai-rating-methodology.
- Altman Z-Score
- A bankruptcy early-warning system developed by Edward Altman: several balance-sheet ratios are combined into one score. We use the Z″ variant, built from four balance-sheet ratios — it is designed for service companies and non-manufacturers and uses book value instead of market value. Values from 2.6 up are considered a safe zone, values below 1.1 a distress zone with elevated bankruptcy risk; in between lies a grey area. Because the classic Altman Z is calculated differently, the two numbers are not directly comparable. The formula does not fit banks, insurers, or real-estate stocks.
- Analysis (Full Company Analysis)
- If the Analysis column shows "Read," there is an in-depth TickerGuard company analysis for this stock: business model, scanner findings, quarterly results, evidence from SEC filings, plus opportunities and risks. One click opens it directly.
- Avg/Yr 3Y (Average Annual Return)
- The stock's average annual return over the past 3 years. Shows at a glance whether a stock delivers over the long run or just had a short hot streak.
- Earnings Date
- The date of the next quarterly earnings report. Price gaps in either direction are common around this date - that is why we color it red when it is 7 days away or less, and yellow when it is 14 days away or less: elevated risk for fresh positions.
- EPS (Earnings per Share)
- Quarterly earnings divided by the number of shares outstanding. The most important growth metric: if EPS rises strongly over several quarters, the company is earning more money per share.
- Free Cash Flow (FCF)
- Operating cash flow minus capital expenditures - the money left over for everything else (debt paydown, acquisitions, or buybacks). Consistently positive free cash flow is one of the most honest signs of a healthy business model.
- Funda Rating (Fundamental Rating A+ to F)
- Our proprietary fundamental rating from 0 to 100 points with a school-grade rank from A+ to F. 50 points is the average across the universe, 100 the best possible score. Every stock is scored against all others by percentile: growth in earnings and revenue, earnings surprises, analyst estimates, and quality criteria such as margins, cash flow, and balance-sheet strength. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below — A/A+ are the fundamentally strongest stocks in the universe.
- Going Concern
- The assumption in a company's annual report that it can continue operating. If auditors raise "substantial doubt" about this, it is one of the sharpest warnings there is - the company could run out of cash.
- Long / Short
- Long = betting on rising prices (buying the stock). Short = betting on falling prices (selling borrowed shares to buy them back cheaper later). Our short scanners are warning or watch lists - not buy candidates.
- Market Capitalization (Mkt Cap)
- The market value of the company: share price x total shares outstanding, shown here in billions of dollars. Micro caps (< $0.3B) are small and volatile, mega caps (> $200B) are heavyweights. Our scanner universe is deliberately capped at $50B - we look for stocks with room to run.
- Net Margin
- How much of revenue is left as profit? Net income divided by revenue, in percent. A 20% margin means: out of every dollar of revenue, 20 cents is left as profit. Rising margins are a strong quality signal.
- Operating Cash Flow (OCF)
- The cash that actually flows into the company from day-to-day operations - without accounting effects such as depreciation. A company can report book profits while still burning cash; operating cash flow reveals that.
- Piotroski F-Score
- A balance-sheet health check developed by Joseph Piotroski: 9 yes/no criteria covering earnings, cash flow, leverage, and efficiency produce a score from 0 to 9. Scores of 7 or higher are considered financially very solid, scores under 3 a warning sign.
- Sector & Industry
- Two levels of industry classification: sector is broad (e.g., Technology), industry is narrow (e.g., Semiconductors). Many strategies watch industry strength, because strong stocks are almost always found in strong industries.
- Stage (Weinstein Stages 1-4)
- Stan Weinstein divides every price chart into four stages: Stage 1 = basing (sideways after a downtrend), Stage 2 = uptrend (the only buying stage), Stage 3 = topping, Stage 4 = downtrend (avoid, or short candidate). Measured against the 30-week line (150-day moving average) and its slope.
- Stress RS (Strength on Stress Days)
- A stress day is a day on which both the overall market and the stock's own sector fell at least 0.5%. Stress RS counts on how many of these days the stock still closed green (shown as "g/n" = green days out of n stress days) and turns that into a rating from 1 to 99. High values point to buyers stepping in even on weak days - often a sign of institutional accumulation.
Hit List
Filter ▾
Rating (traffic light)
Stage
Funda Rating
Piotroski
Columns ▾
This scanner's columns
Extra columns
Tip: clicking a column header sorts the table by that column; a second click flips the direction.
| Symbol | Earnings | Avg/Y 3Y | Stress RS | Stage | Funda Rating | Piotroski | MktCap | Industry | AI Rating | Deep Dive | Deep-Dive Report | Sector | Price | YTD | 6 Mo. | 1 Year | Off High | Price Target | RS | EPS Rating | ADR 10D | ADR 30D | Beta | P/E | P/E (f) | P/S | P/B | P/FCF | PEG | EV/EBITDA | EBIT Margin | Gross Margin | Net Margin | ROE | ROA | Debt/Eq | Equity Ratio | Sales +/Y | Growth Score | Div. Yield | Payout Ratio | Altman Z | Inst. % | Short % | Analysts |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OTLK OUTLOOK THERAPEUTICS INC | 08/13 | -32 % | 71 6/22 | Stage 3 | D 29 | 4 of 9 | 0.1 $ | Biotechnology | Uses AI | — | Healthcare | 0.98 $ | +7.6 % | -7.7 % | -50.2 % | −52.5 % | +241.6 % | 97 | 42 | 16.8 % | 20.7 % | 0.78 | — | 2.8 | 483.3 | — | — | — | -4.1 | — | -360.8 % | 0.0 % | -3.7 % | -184.8 % | — | — | +730.9 % | — | 0.0 % | 0.0 % | -116.1 | 6.9 % | 10.1 % | — | |
| PIII P3 Health Partners Inc | 08/13 | -33 % | 83 7/22 | Stage 2 | D 42 | 6 of 9 | 0.1 $ | Medical Care Facilities | Uses AI | — | — | Healthcare | 9.80 $ | +243.6 % | +18.1 % | +32.5 % | −36.8 % | +31.1 % | 97 | 42 | 10.2 % | 16.8 % | 1.62 | — | 0.0 | 0.0 | 0.6 | — | — | -1.9 | — | -0.8 % | -8.6 % | -6,952.6 % | -19.2 % | -0.43 | — | -2.8 % | — | 0.0 % | 0.0 % | -5.7 | 7.3 % | 2.7 % | — |
| CELC Celcuity LLC | 08/13 | +65 % | 80 7/22 | Stage 1 | C 47 | 2 of 9 | 4.3 $ | Biotechnology | Neutral | — | — | Healthcare | 86.40 $ | -9.6 % | -0.1 % | +120.6 % | −36.5 % | +89.3 % | 96 | 42 | 5.5 % | 7.2 % | 0.16 | — | 0.0 | 21,410.0 | — | — | — | -7.8 | 0.0 % | — | 0.0 % | -275.2 % | -37.1 % | — | 13.1 % | — | — | 0.0 % | 0.0 % | 2.6 | 101.2 % | 34.4 % | 4.7 (7) |
| SVCO Silvaco Group, Inc. Common Stock | 08/05 | — | 74 7/25 | Stage 2 | D 43 | 4 of 9 | 0.3 $ | Software - Application | Sells AI | — | — | Technology | 7.80 $ | +218.0 % | +185.7 % | +74.8 % | −15.5 % | +26.9 % | 96 | 42 | 9.8 % | 9.6 % | 0.39 | — | 416.7 | 3.9 | 3.4 | — | — | 194.4 | — | 80.5 % | -41.7 % | -34.7 % | -12.9 % | 0.03 | — | +5.7 % | — | 0.0 % | 0.0 % | 2.2 | 24.3 % | 9.5 % | — |
| BWEN Broadwind Energy Inc | 08/11 | -14 % | 49 6/29 | Stage 2 | D 44 | 7 of 9 | 0.1 $ | Specialty Industrial Machinery | Neutral | — | Industrials | 4.00 $ | +71.4 % | -31.1 % | +54.4 % | −20.2 % | +39.2 % | 95 | 97 | 12.1 % | 12.5 % | 1.75 | 17.5 | 43.3 | 0.6 | 1.4 | — | 1.05 | 8.9 | — | 10.6 % | 3.3 % | 8.2 % | 0.3 % | 0.42 | — | +10.4 % | — | 0.0 % | 0.0 % | -2.5 | 31.7 % | 3.1 % | — | |
| SKYT Skywater Technology Inc | 08/05 | +114 % | 34 4/25 | Stage 2 | B 64 | 4 of 9 | 1.6 $ | Semiconductors | Neutral | — | — | Technology | 32.50 $ | +101.2 % | +99.1 % | +239.9 % | −12.9 % | +7.7 % | 95 | 99 | 5.1 % | 4.8 % | 3.34 | 14.2 | 185.2 | 3.0 | 8.9 | — | — | 11.8 | -3.3 % | 19.4 % | 21.0 % | 95.9 % | -0.4 % | 1.32 | 24.6 % | +29.2 % | — | 0.0 % | 0.0 % | 2.8 | 61.4 % | 7.3 % | 4.2 (5) |
| URGN UroGen Pharma Ltd | 08/06 | +18 % | 69 6/22 | Stage 2 | B 57 | 3 of 9 | 1.8 $ | Biotechnology | Uses AI | — | — | Healthcare | 38.20 $ | +50.1 % | +51.8 % | +100.6 % | −4.7 % | +17.1 % | 94 | 42 | 5.1 % | 5.4 % | 1.58 | — | 0.0 | 13.1 | — | — | — | -2.6 | -39.8 % | 89.9 % | -94.8 % | -1,481.3 % | -27.0 % | — | -49.0 % | +21.5 % | — | 0.0 % | 0.0 % | -8.0 | 100.6 % | 11.9 % | 4.4 (8) |
| GCTS GCT Semiconductor Holding Inc | 08/11 | -32 % | 96 11/25 | Stage 2 | D 43 | 6 of 9 | 0.2 $ | Semiconductors | Neutral | — | — | Technology | 1.90 $ | +139.2 % | +106.5 % | +36.8 % | −37.2 % | +40.4 % | 94 | 42 | 11.3 % | 15.8 % | 1.78 | — | 0.0 | 40.0 | 0.0 | — | — | -21.3 | — | -22.3 % | 0.0 % | 0.0 % | -109.6 % | -0.79 | — | -68.6 % | — | 0.0 % | 0.0 % | -114.5 | 4.9 % | 9.6 % | — |
| QMCO Quantum Corporation | — | -32 % | 62 6/25 | Stage 2 | D 42 | 4 of 9 | 0.3 $ | Computer Hardware | Uses AI | — | Technology | 10.60 $ | +114.1 % | +60.8 % | +32.8 % | −30.0 % | +55.7 % | 94 | 42 | 14.0 % | 14.5 % | 2.96 | — | 1.9 | 1.2 | 0.1 | — | 0.77 | 236.9 | — | 36.9 % | -36.1 % | 0.0 % | -6.6 % | -0.04 | — | -12.1 % | — | 0.0 % | 0.0 % | -26.0 | 12.8 % | 5.8 % | 3.0 (2) | |
| RFL Rafael Holdings, Inc. | — | +9 % | 84 7/21 | Stage 2 | D 32 | 2 of 9 | 0.1 $ | Real Estate Services | Neutral | — | — | Real Estate | 1.90 $ | +126.3 % | +167.8 % | +14.8 % | −8.1 % | — | 94 | 42 | 12.5 % | 10.6 % | 0.29 | — | 0.0 | 112.2 | 1.3 | — | — | 5.4 | — | 95.1 % | 0.0 % | -37.6 % | -22.8 % | 0.01 | — | +44.0 % | — | 0.0 % | 0.0 % | 0.8 | 7.3 % | 0.3 % | — |
| PGEN Precigen Inc | 08/11 | +125 % | 39 4/22 | Stage 2 | C 54 | 4 of 9 | 2.2 $ | Biotechnology | Neutral | — | — | Healthcare | 6.30 $ | +28.2 % | +41.3 % | +266.7 % | −2.8 % | +98.4 % | 93 | 42 | 6.5 % | 6.9 % | 1.01 | — | 312.5 | 70.9 | 117.8 | — | — | -3.3 | -25.8 % | -35.4 % | 0.0 % | -1,145.4 % | -42.1 % | 4.86 | 14.6 % | +146.7 % | — | 0.0 % | 0.0 % | -57.6 | 71.1 % | 21.2 % | 3.8 (4) |
| REPL Replimune Group Inc | 07/02 | -31 % | 55 5/22 | Stage 3 | D 32 | 1 of 9 | 0.9 $ | Biotechnology | Neutral | — | Healthcare | 11.20 $ | +17.5 % | -40.2 % | +59.3 % | −15.9 % | +7.1 % | 92 | 42 | 9.2 % | 10.0 % | 0.87 | — | 0.0 | 615.3 | 4.6 | — | — | -0.2 | — | — | 0.0 % | -90.9 % | -45.0 % | 0.36 | — | — | — | 0.0 % | 0.0 % | -8.4 | 96.9 % | 49.9 % | 4.4 (8) | |
| ARMP Armata Pharmaceuticals Inc | 08/11 | +51 % | 56 5/22 | Stage 1 | D 29 | 4 of 9 | 0.2 $ | Biotechnology | Neutral | — | — | Healthcare | 4.50 $ | +11.6 % | +0.8 % | +85.3 % | −60.2 % | +169.2 % | 91 | 42 | 11.0 % | 10.5 % | 1.27 | — | 0.0 | 31.3 | — | — | — | -3.5 | — | -215.2 % | 0.0 % | -3,439.4 % | -25.3 % | — | — | -5.2 % | — | 0.0 % | 0.0 % | -52.2 | 10.5 % | 1.9 % | — |
| SPIR Spire Global Inc | 08/12 | +124 % | 85 10/29 | Stage 2 | D 40 | 4 of 9 | 0.5 $ | Specialty Business Services | Sells AI | — | — | Industrials | 11.50 $ | +132.5 % | +114.7 % | +14.3 % | −38.3 % | +81.5 % | 90 | 42 | 9.1 % | 11.1 % | 2.52 | 7.4 | 0.0 | 6.7 | 5.2 | — | — | 5.9 | — | 42.3 % | 77.1 % | 101.2 % | -27.2 % | 0.13 | — | -35.2 % | — | 0.0 % | 0.0 % | -8.1 | 39.9 % | 11.8 % | 4.6 (5) |
| BTDR Bitdeer Technologies Group | 08/17 | +17 % | 73 7/25 | Stage 3 | B 62 | 3 of 9 | 2.6 $ | Software - Application | Sells AI | — | Technology | 10.50 $ | +53.7 % | +38.0 % | -18.4 % | −41.0 % | +113.3 % | 89 | 42 | 10.6 % | 10.4 % | 2.47 | — | 1,000.0 | 3.5 | 3.7 | — | — | 13.2 | -43.4 % | 3.5 % | -27.0 % | -26.1 % | 6.2 % | 2.78 | 23.5 % | +77.3 % | — | 0.0 % | 0.0 % | 4.7 | 70.9 % | 36.8 % | 4.7 (12) | |
| GLSI Greenwich Lifesciences Inc | 08/13 | +46 % | 29 3/22 | Stage 2 | E 22 | 5 of 9 | 0.2 $ | Biotechnology | Neutral | — | — | Healthcare | 13.50 $ | +9.6 % | +35.1 % | +23.4 % | −46.3 % | +159.1 % | 89 | 42 | 11.0 % | 9.4 % | 1.39 | — | 0.0 | — | 40.6 | — | — | -21.2 | — | — | 0.0 % | -676.7 % | -211.3 % | — | — | — | — | 0.0 % | 0.0 % | -19.1 | 12.4 % | 19.1 % | — |
| NRXP NRX Pharmaceuticals Inc | 08/17 | -8 % | 30 3/22 | Stage 2 | B 65 | 6 of 9 | 0.1 $ | Biotechnology | Neutral | — | — | Healthcare | 3.20 $ | +38.7 % | +63.9 % | +17.1 % | −29.6 % | +1,079.8 % | 89 | 42 | 8.5 % | 10.2 % | 2.19 | — | 34.2 | 63.5 | — | — | — | -0.2 | — | 50.5 % | 0.0 % | -682.6 % | -110.2 % | — | — | — | — | 0.0 % | 0.0 % | -97.1 | 17.5 % | 13.9 % | — |
| SHLS Shoals Technologies Group Inc | 08/04 | -19 % | 62 6/25 | Stage 2 | B 57 | 2 of 9 | 1.6 $ | Solar | Neutral | — | Technology | 8.70 $ | +20.9 % | +1.1 % | +62.2 % | −25.2 % | +27.0 % | 87 | 66 | 8.6 % | 9.1 % | 1.90 | — | 20.3 | 2.9 | — | — | 0.85 | 23.6 | 8.1 % | 33.5 % | 6.3 % | 5.8 % | 5.5 % | — | 58.4 % | +19.1 % | — | 0.0 % | 0.0 % | 6.6 | 121.3 % | 11.4 % | 4.0 (21) | |
| HURA TuHURA Biosciences Inc | 08/13 | -33 % | 82 7/22 | Stage 3 | E 19 | 3 of 9 | 0.1 $ | Biotechnology | Neutral | — | Healthcare | 2.20 $ | +248.7 % | +177.9 % | -12.5 % | −33.6 % | +210.4 % | 86 | 42 | 10.2 % | 9.0 % | — | — | 0.0 | — | — | — | — | 0.0 | — | — | 0.0 % | -187.2 % | -81.9 % | — | — | — | — | 0.0 % | 0.0 % | -16.0 | 15.0 % | 15.8 % | — | |
| BZFD BuzzFeed Inc | 08/06 | -20 % | 75 7/24 | Stage 3 | D 25 | 4 of 9 | 0.1 $ | Internet Content & Information | Threatened | — | — | Communication Services | 1.20 $ | +64.5 % | -12.4 % | -45.2 % | −50.0 % | -25.4 % | 86 | 13 | 10.5 % | 12.3 % | 3.77 | — | 172.4 | 0.5 | — | — | — | -7.7 | — | 40.3 % | -33.3 % | -90.2 % | -5.3 % | — | — | -2.4 % | — | 0.0 % | 0.0 % | -12.8 | 10.0 % | 3.2 % | — |
| ATRA Atara Biotherapeutics Inc | 08/10 | -29 % | 81 7/22 | Stage 3 | D 36 | 4 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 8.40 $ | -38.3 % | -67.1 % | -27.3 % | −46.6 % | +33.7 % | 85 | 42 | 8.3 % | 8.3 % | 0.09 | — | 232.6 | 3.3 | 13.3 | — | — | 2.2 | — | 70.1 % | -40.9 % | -2,014.9 % | -3.8 % | -0.27 | — | -6.3 % | — | 0.0 % | 0.0 % | -327.5 | 52.5 % | 7.8 % | — |
| CVU CPI Aerostructures Inc | 08/18 | +10 % | 67 8/29 | Stage 2 | D 43 | 5 of 9 | 0.1 $ | Aerospace & Defense | – | — | — | Industrials | 5.00 $ | +25.8 % | +45.2 % | +46.5 % | −11.5 % | -16.3 % | 85 | 18 | 5.0 % | 6.7 % | 1.02 | 43.9 | 6.8 | 1.0 | 2.6 | — | 0.67 | 32.1 | — | 18.8 % | 2.4 % | 6.6 % | 2.5 % | 1.05 | — | -14.6 % | — | 0.0 % | 0.0 % | 4.0 | 22.9 % | 0.4 % | — |
| FTAI FTAI Aviation Ltd. | 08/04 | +283 % | 76 9/29 | Stage 2 | B 68 | 5 of 9 | 21.0 $ | Aerospace & Defense | – | — | — | Industrials | 206.00 $ | +33.6 % | +52.7 % | +50.9 % | −17.0 % | +82.8 % | 83 | 77 | 6.6 % | 6.4 % | 1.51 | 41.0 | 28.5 | 6.8 | 49.0 | — | 3.22 | 22.2 | 22.5 % | 32.2 % | 15.9 % | 233.3 % | 11.4 % | 10.23 | 9.5 % | +43.2 % | — | 1.0 % | 34.1 % | 8.0 | 97.2 % | 10.6 % | 4.5 (13) |
| SHIM Shimmick Corporation Common Stock | 08/13 | — | 49 6/29 | Stage 1 | D 41 | 4 of 9 | 0.2 $ | Engineering & Construction | Neutral | — | — | Industrials | 3.80 $ | +25.3 % | +50.2 % | +113.6 % | −39.7 % | +83.8 % | 83 | 42 | 7.6 % | 8.4 % | 0.71 | — | 72.5 | 0.3 | 65.0 | — | — | 1,635.2 | — | 8.7 % | -4.4 % | -696.6 % | -4.3 % | -1.33 | — | +2.6 % | — | 0.0 % | 0.0 % | 0.3 | 8.7 % | 0.2 % | — |
| PLUG Plug Power Inc | 08/10 | -24 % | 66 8/29 | Stage 2 | D 43 | 3 of 9 | 2.9 $ | Electrical Equipment & Parts | – | — | — | Industrials | 2.10 $ | +37.6 % | +23.3 % | +37.3 % | −43.9 % | +68.9 % | 82 | 42 | 6.8 % | 8.2 % | 2.17 | — | 13.1 | 4.0 | 3.9 | — | 0.84 | -2.2 | -63.6 % | -31.2 % | -227.1 % | -128.8 % | -13.6 % | 1.35 | 31.7 % | +12.9 % | — | 0.0 % | 0.0 % | -10.6 | 68.9 % | 26.7 % | 3.2 (20) |
| AEVA Aeva Technologies, Inc. | 07/30 | +100 % | 80 8/25 | Stage 2 | C 50 | 5 of 9 | 1.3 $ | Software - Infrastructure | – | — | — | Technology | 17.50 $ | +77.3 % | +90.3 % | -5.9 % | −48.1 % | +43.6 % | 81 | 42 | 12.5 % | 12.1 % | 2.40 | — | 0.0 | 60.6 | 68.6 | — | — | -0.1 | — | 4.6 % | 0.0 % | -516.1 % | -63.2 % | -8.22 | — | +99.4 % | — | 0.0 % | 0.0 % | -16.8 | 66.1 % | 10.2 % | 4.4 (5) |
| ACHV Achieve Life Sciences Inc | 08/06 | -5 % | 56 5/22 | Stage 2 | D 26 | 3 of 9 | 0.7 $ | Biotechnology | – | — | — | Healthcare | 6.40 $ | +0.8 % | +39.7 % | +146.0 % | −7.5 % | +115.6 % | 79 | 42 | 8.7 % | 8.2 % | 2.22 | — | 35.3 | — | — | — | 17.68 | -2.4 | — | — | 0.0 % | -496.2 % | -108.4 % | — | — | -100.0 % | — | 0.0 % | 0.0 % | -29.4 | 61.0 % | 14.4 % | 4.9 (8) |
| PYXS Pyxis Oncology Inc | 08/13 | -7 % | 83 7/22 | Stage 3 | D 42 | 1 of 9 | 0.2 $ | Biotechnology | – | — | — | Healthcare | 2.70 $ | +82.6 % | +157.7 % | +136.6 % | −59.8 % | +202.7 % | 79 | 42 | 12.6 % | 11.3 % | 1.31 | — | 0.0 | — | 5.3 | — | — | 1.1 | — | 82.8 % | 0.0 % | -121.7 % | -51.9 % | 0.58 | — | -14.2 % | — | 0.0 % | 0.0 % | -24.8 | 33.9 % | 4.3 % | — |
| RDZN Roadzen Inc. | — | -31 % | 74 7/25 | Stage 1 | C 51 | 4 of 9 | 0.1 $ | Software - Application | Sells AI | — | — | Technology | 1.20 $ | -36.1 % | -24.9 % | -8.7 % | −43.4 % | +244.8 % | 79 | 42 | 9.6 % | 8.4 % | 1.20 | — | 0.0 | 2.0 | — | — | — | -4.4 | — | 61.3 % | -40.9 % | 0.0 % | -20.5 % | — | — | -5.2 % | — | 0.0 % | 0.0 % | -20.2 | 3.0 % | 1.2 % | — |
| BHVN Biohaven Ltd. | 08/10 | -12 % | 14 2/22 | Stage 3 | D 32 | 2 of 9 | 2.1 $ | Biotechnology | – | — | — | Healthcare | 13.50 $ | +30.9 % | +38.3 % | -10.6 % | −17.4 % | +69.9 % | 78 | 42 | 9.3 % | 8.9 % | 3.14 | — | 0.0 | — | 16.2 | — | — | -2.2 | 0.0 % | — | 0.0 % | -333.0 % | -83.4 % | 2.21 | 27.8 % | -100.0 % | — | 0.0 % | 0.0 % | -16.5 | 97.6 % | 16.5 % | 4.6 (16) |
| TBI TrueBlue Inc | 08/03 | -21 % | 60 7/29 | Stage 2 | D 36 | 3 of 9 | 0.2 $ | Staffing & Employment Services | – | — | — | Industrials | 7.10 $ | +41.5 % | +50.6 % | -1.9 % | −16.1 % | +30.2 % | 78 | 11 | 5.5 % | 6.1 % | 1.61 | — | 68.0 | 0.1 | 0.8 | — | 4.86 | 403.0 | — | 21.7 % | -3.3 % | -19.1 % | -3.6 % | 0.51 | — | +3.1 % | — | 0.0 % | 0.0 % | 6.6 | 92.5 % | 4.4 % | — |
| LASE Laser Photonics Corporation | 08/21 | -32 % | 90 11/29 | Stage 3 | D 25 | 2 of 9 | 0.1 $ | Specialty Industrial Machinery | Sells AI | — | Industrials | 0.98 $ | — | — | -64.8 % | −71.3 % | — | 77 | 3 | 16.3 % | 17.9 % | 2.27 | — | 0.0 | 7.2 | 5.8 | — | — | 28.8 | -303.2 % | -1.2 % | -268.7 % | -727.4 % | -48.1 % | — | -53.3 % | +132.0 % | — | 0.0 % | 0.0 % | -4.9 | 12.0 % | 9.3 % | 5.0 (1) | |
| LTRN Lantern Pharma Inc | 08/12 | -8 % | 57 5/22 | Stage 3 | D 29 | 2 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 2.60 $ | +26.4 % | +21.9 % | -40.8 % | −36.1 % | +445.0 % | 77 | 42 | 8.4 % | 10.3 % | 2.29 | — | 0.0 | — | 10.1 | — | — | 0.2 | — | — | 0.0 % | -157.4 % | -73.3 % | 0.02 | — | — | — | 0.0 % | 0.0 % | -51.2 | 14.2 % | 10.8 % | — |
| LGIH LGI Homes | 08/04 | -19 % | 8 2/31 | Stage 2 | D 36 | 4 of 9 | 1.2 $ | Residential Construction | – | — | — | Consumer Cyclical | 54.60 $ | +30.5 % | +47.6 % | +2.4 % | −9.9 % | +70.3 % | 73 | 16 | 6.5 % | 6.0 % | 1.82 | — | 18.8 | 0.7 | — | — | 0.69 | 35.0 | -0.1 % | 20.5 % | 4.2 % | 3.4 % | 1.3 % | — | 52.4 % | -22.6 % | — | 0.0 % | 0.0 % | 12.1 | 91.2 % | 20.4 % | 3.0 (6) |
| CABA Cabaletta Bio Inc | 08/06 | -25 % | 29 3/22 | Stage 2 | E 23 | 2 of 9 | 0.4 $ | Biotechnology | – | — | — | Healthcare | 2.70 $ | +37.9 % | +42.0 % | +76.3 % | −31.0 % | +395.4 % | 73 | 42 | 7.4 % | 7.4 % | 3.26 | — | 0.0 | — | — | — | — | -3.4 | — | — | 0.0 % | -156.0 % | -71.6 % | — | — | -100.0 % | — | 0.0 % | 0.0 % | -10.9 | 63.6 % | 27.8 % | 4.5 (12) |
| SCLX Scilex Holding Company | 08/12 | -32 % | 58 5/22 | Stage 3 | D 40 | 4 of 9 | 0.0 $ | Drug Manufacturers - General | Neutral | — | — | Healthcare | 6.60 $ | -9.4 % | -9.4 % | -20.2 % | −79.3 % | +6,811.1 % | 72 | 42 | 13.4 % | 12.2 % | 1.73 | — | 2.7 | 1.4 | — | — | — | -2.6 | — | 59.7 % | 0.0 % | 0.0 % | -92.8 % | — | — | -46.5 % | — | 0.0 % | 0.0 % | -26.0 | 13.1 % | 3.7 % | — |
| TKNO Alpha Teknova Inc | 08/06 | +21 % | 83 7/22 | Stage 3 | C 52 | 5 of 9 | 0.3 $ | Drug Manufacturers - Specialty & Generic | – | — | — | Healthcare | 5.00 $ | +28.7 % | +38.0 % | +10.6 % | −18.3 % | +64.8 % | 71 | 42 | 9.2 % | 9.9 % | 0.63 | — | 0.0 | 6.3 | 3.9 | — | — | -6.2 | — | 34.0 % | -41.1 % | -23.9 % | -9.3 % | 0.23 | — | +7.4 % | — | 0.0 % | 0.0 % | 1.2 | 84.7 % | 9.0 % | — |
| CLF Cleveland-Cliffs Inc | 07/20 | -10 % | 22 3/23 | Stage 1 | D 43 | 3 of 9 | 7.0 $ | Steel | – | — | — | Basic Materials | 11.50 $ | -16.0 % | -31.8 % | +9.5 % | −35.6 % | +2.2 % | 68 | 1 | 6.0 % | 6.5 % | 2.14 | — | 29.7 | 0.4 | 1.0 | — | 0.43 | 29.5 | -2.9 % | -1.1 % | -4.6 % | -18.6 % | -1.7 % | 1.33 | 28.9 % | -3.0 % | — | 0.0 % | 0.0 % | 4.3 | 84.0 % | 14.8 % | 3.1 (13) |
| EYPT Eyepoint Pharmaceuticals Inc | 08/05 | -8 % | 69 6/22 | Stage 1 | D 34 | 1 of 9 | 1.0 $ | Biotechnology | – | — | — | Healthcare | 12.30 $ | -21.3 % | -22.7 % | +24.8 % | −28.3 % | +229.3 % | 59 | 42 | 6.7 % | 6.3 % | 1.74 | — | 6.2 | 136.3 | 4.5 | — | — | 11.6 | — | -2,951.8 % | 0.0 % | -102.7 % | -54.1 % | 0.09 | — | -27.5 % | — | 0.0 % | 0.0 % | -7.3 | 111.8 % | 20.7 % | 4.7 (13) |
| SMHI SEACOR Marine Holdings Inc | 07/29 | -10 % | 67 8/29 | Stage 2 | C 54 | 3 of 9 | 0.3 $ | Marine Shipping | – | — | — | Industrials | 9.40 $ | +30.6 % | +26.7 % | +88.6 % | −7.6 % | +45.7 % | 59 | 42 | 8.4 % | 6.2 % | 1.10 | — | 0.0 | 1.2 | 1.0 | — | — | 8.0 | — | 17.6 % | -13.0 % | -10.6 % | -4.9 % | 1.33 | — | -16.0 % | — | 0.0 % | 0.0 % | 4.4 | 46.6 % | 3.6 % | — |
| BIRD Allbirds Inc | 08/06 | -32 % | 21 4/31 | Stage 3 | E 17 | 3 of 9 | 0.0 $ | Apparel Retail | – | — | — | Consumer Cyclical | 2.20 $ | +24.9 % | -84.6 % | -78.0 % | −82.4 % | +227.1 % | 57 | 42 | 23.0 % | 13.8 % | 2.56 | — | 0.0 | 0.2 | 1.4 | — | — | -0.6 | — | 38.1 % | -53.4 % | -153.7 % | -38.8 % | 2.04 | — | -19.7 % | — | 0.0 % | 0.0 % | -23.1 | 35.4 % | 16.9 % | — |
| VUZI Vuzix Corp Cmn Stk | 08/13 | -13 % | 20 3/25 | Stage 2 | D 37 | 4 of 9 | 0.2 $ | Consumer Electronics | – | — | — | Technology | 2.30 $ | -18.5 % | -14.4 % | +15.9 % | −51.1 % | +118.2 % | 57 | 42 | 8.6 % | 11.9 % | 1.75 | — | 0.0 | 31.8 | — | — | — | -1.1 | — | -9.7 % | 0.0 % | -91.9 % | -51.9 % | — | — | +9.1 % | — | 0.0 % | 0.0 % | -25.0 | 37.0 % | 17.5 % | — |
| EFC Ellington Financial Inc. | 08/06 | +16 % | 31 3/21 | Stage 2 | B 66 | 7 of 9 | 1.7 $ | REIT - Mortgage | Uses AI | — | — | Real Estate | 13.30 $ | +4.5 % | +4.8 % | +17.8 % | −3.3 % | +11.2 % | 56 | 87 | 1.7 % | 1.5 % | 0.93 | — | 9.1 | 2.8 | — | — | 0.86 | 0.0 | 59.4 % | 100.0 % | 53.4 % | 12.2 % | 1.2 % | — | 9.5 % | +139.0 % | — | 11.8 % | 29.2 % | 1.9 | 53.3 % | 6.3 % | 4.0 (8) |
| FF FutureFuel Corp | 08/10 | -7 % | 91 9/23 | Stage 2 | D 39 | 5 of 9 | 0.2 $ | Specialty Chemicals | Threatened | — | Basic Materials | 5.00 $ | +29.7 % | +45.7 % | +28.4 % | −19.7 % | +240.6 % | 56 | 4 | 4.4 % | 4.2 % | 0.96 | — | 16.3 | 2.0 | 1.6 | — | — | 11.4 | — | -36.4 % | -47.1 % | -31.4 % | -16.7 % | — | — | -60.7 % | — | 3.0 % | 68.6 % | 6.6 | 36.0 % | 2.6 % | — | |
| KULR KULR Technology Group Inc | 08/13 | -9 % | 20 3/25 | Stage 2 | C 49 | 4 of 9 | 0.1 $ | Electronic Components | – | — | — | Technology | 2.70 $ | +30.4 % | +11.8 % | -51.7 % | −52.9 % | +113.9 % | 56 | 42 | 9.7 % | 11.7 % | 2.26 | — | 128.2 | 6.7 | — | — | — | -6.4 | — | -0.8 % | 0.0 % | -77.3 % | -25.1 % | — | — | +50.6 % | — | 0.0 % | 0.0 % | 2.9 | 22.6 % | 21.2 % | — |
| CHRS Coherus BioSciences Inc | 08/06 | -21 % | 40 4/22 | Stage 4 | D 42 | 5 of 9 | 0.2 $ | Biotechnology | – | — | — | Healthcare | 1.40 $ | +2.8 % | +8.2 % | +50.0 % | −43.4 % | +427.0 % | 55 | 7 | 6.0 % | 5.9 % | 0.98 | — | 41.2 | 4.7 | 2.8 | — | — | 1.3 | — | 68.1 % | 397.3 % | 33.1 % | -32.8 % | 0.69 | — | -84.2 % | — | 0.0 % | 0.0 % | -16.1 | 38.6 % | 17.1 % | — |
| SMCI Super Micro Computer Inc | 08/04 | +18 % | 10 2/25 | Stage 3 | B 65 | 4 of 9 | 19.6 $ | Computer Hardware | – | — | — | Technology | 28.40 $ | +13.8 % | -7.9 % | -51.8 % | −49.2 % | +33.1 % | 54 | 93 | 8.8 % | 9.6 % | 1.94 | 14.5 | 8.7 | 0.6 | 2.3 | — | 0.91 | 14.7 | 6.1 % | 8.4 % | 3.7 % | 17.9 % | 5.5 % | 0.89 | 32.3 % | +47.0 % | — | 0.0 % | 0.0 % | 8.6 | 62.5 % | 19.6 % | 3.3 (18) |
| EDIT Editas Medicine Inc | 08/11 | -27 % | 29 3/22 | Stage 3 | D 42 | 2 of 9 | 0.4 $ | Biotechnology | Neutral | — | Healthcare | 2.60 $ | +27.8 % | +27.2 % | +2.8 % | −36.9 % | +130.8 % | 54 | 42 | 8.7 % | 10.1 % | 2.10 | — | 0.0 | 10.3 | 92.6 | — | — | -1.4 | -883.2 % | -109.2 % | -281.6 % | -326.1 % | -27.0 % | 0.40 | 14.6 % | +25.4 % | — | 0.0 % | 0.0 % | -11.5 | 49.4 % | 14.5 % | 3.5 (15) | |
| PDSB PDS Biotechnology Corp | 08/12 | -28 % | 82 7/22 | Stage 2 | D 27 | 1 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 0.69 $ | +18.5 % | +0.6 % | -35.9 % | −44.8 % | +742.7 % | 53 | 42 | 9.6 % | 11.2 % | 1.58 | — | 0.0 | — | 9.7 | — | — | -2.6 | — | — | 0.0 % | -254.1 % | -50.5 % | 4.08 | — | — | — | 0.0 % | 0.0 % | -28.7 | 9.2 % | 2.8 % | — |
| LZM Lifezone Metals Limited | 07/29 | -20 % | 86 8/23 | Stage 4 | C 54 | 5 of 9 | 0.3 $ | Other Industrial Metals & Mining | – | — | — | Basic Materials | 3.40 $ | -0.5 % | -13.9 % | -23.1 % | −36.7 % | +113.0 % | 50 | 42 | 8.6 % | 8.6 % | 1.27 | — | 0.0 | 260.8 | — | — | — | -1.1 | — | 49.5 % | 0.0 % | -16.4 % | -6.8 % | — | — | +652.2 % | — | 0.0 % | 0.0 % | -9.1 | 25.8 % | 0.1 % | — |
| RARE Ultragenyx | 08/04 | -14 % | 69 6/22 | Stage 3 | D 37 | 0 of 9 | 2.5 $ | Biotechnology | – | — | — | Healthcare | 24.90 $ | +25.0 % | -11.3 % | -8.8 % | −31.0 % | +114.3 % | 48 | 42 | 5.5 % | 5.2 % | 0.31 | — | 0.0 | 3.7 | — | — | — | -6.5 | -102.2 % | -28.1 % | -90.9 % | -608.5 % | -25.5 % | — | -18.2 % | +20.1 % | — | 0.0 % | 0.0 % | -9.9 | 104.2 % | 14.1 % | 4.6 (20) |
| RGNX Regenxbio Inc | 08/06 | -16 % | 15 2/22 | Stage 4 | D 27 | 1 of 9 | 0.5 $ | Biotechnology | – | — | — | Healthcare | 9.70 $ | -30.9 % | -18.2 % | +13.9 % | −36.8 % | +150.2 % | 46 | 42 | 13.1 % | 9.4 % | 0.90 | — | 0.0 | 5.6 | — | — | 0.26 | -3.4 | — | -196.6 % | 0.0 % | -196.4 % | -38.5 % | — | — | +104.5 % | — | 0.0 % | 0.0 % | -10.9 | 84.7 % | 18.0 % | 4.4 (12) |
| MATW Matthews International Corporation | 08/04 | -9 % | 23 4/29 | Stage 1 | D 39 | 3 of 9 | 0.9 $ | Conglomerates | – | — | — | Industrials | 27.80 $ | +1.0 % | +1.8 % | +22.9 % | −14.8 % | +36.7 % | 45 | 96 | 3.5 % | 3.4 % | 1.08 | — | 11.1 | 0.7 | — | — | 1.86 | 7.3 | — | 37.1 % | 0.8 % | 2.1 % | 0.7 % | — | — | -16.6 % | — | 3.7 % | 150.0 % | 6.4 | 96.3 % | 14.0 % | 4.5 (2) |
| OSTX OS Therapies Incorporated | 08/17 | — | 82 7/22 | Stage 3 | D 27 | 2 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 1.50 $ | +30.0 % | +47.4 % | -14.6 % | −30.0 % | +422.1 % | 45 | 42 | 8.5 % | 8.3 % | — | — | 1.7 | — | 11.4 | — | — | 0.0 | — | — | 0.0 % | -914.0 % | -366.6 % | -0.12 | — | — | — | 0.0 % | 0.0 % | -78.9 | 6.5 % | 4.9 % | — |
| CNVS Cineverse Corp. | 08/13 | +12 % | 84 8/24 | Stage 3 | D 34 | 1 of 9 | 0.1 $ | Entertainment | – | — | — | Communication Services | 2.40 $ | +35.1 % | +34.0 % | -52.4 % | −63.7 % | +291.8 % | 43 | 42 | 10.7 % | 7.1 % | 1.52 | — | 38.8 | 0.9 | — | — | 0.46 | 10.1 | — | 53.4 % | -13.4 % | -24.5 % | -9.3 % | — | — | +59.1 % | — | 0.0 % | 0.0 % | -20.6 | 16.5 % | 2.7 % | — |
| GUTS Fractyl Health, Inc. Common Stock | 08/11 | — | 57 5/22 | Stage 4 | D 34 | 5 of 9 | 0.1 $ | Biotechnology | Uses AI | — | Healthcare | 0.69 $ | -62.4 % | -64.6 % | -62.8 % | −67.3 % | +529.2 % | 42 | 42 | 8.5 % | 9.6 % | 2.29 | — | 0.0 | — | 5.1 | — | — | 0.0 | — | 100.0 % | 0.0 % | -778.3 % | -63.6 % | 2.85 | — | -100.0 % | — | 0.0 % | 0.0 % | -18.4 | 52.5 % | 1.6 % | — | |
| AOMR Angel Oak Mortgage Inc | 08/04 | +21 % | 19 2/21 | Stage 3 | D 30 | 2 of 9 | 0.2 $ | REIT - Mortgage | – | — | — | Real Estate | 8.90 $ | +7.6 % | +11.2 % | +10.4 % | −13.9 % | +23.1 % | 41 | 10 | 3.2 % | 2.6 % | 1.19 | — | 15.1 | 1.4 | — | — | — | 0.0 | — | 64.6 % | 45.7 % | 6.3 % | 0.6 % | — | — | +158.1 % | — | 14.2 % | 133.3 % | 2.8 | 63.9 % | 2.3 % | — |
| ELUT Elutia Inc. | 08/13 | -20 % | 93 9/22 | Stage 2 | D 32 | 3 of 9 | 0.0 $ | Medical Devices | – | — | — | Healthcare | 0.86 $ | +48.7 % | +71.0 % | -57.8 % | −64.1 % | +426.3 % | 41 | 42 | 7.1 % | 8.1 % | 0.85 | — | 0.0 | 2.7 | 1.8 | — | — | -3.3 | — | 56.3 % | 400.2 % | 0.0 % | -26.4 % | 0.52 | — | -49.6 % | — | 0.0 % | 0.0 % | -7.2 | 45.7 % | 0.1 % | — |
| MXCT MaxCyte Inc | 08/05 | -25 % | 89 8/22 | Stage 3 | D 44 | 3 of 9 | 0.1 $ | Medical Devices | – | — | — | Healthcare | 1.10 $ | -24.2 % | -22.5 % | -49.0 % | −46.4 % | +223.4 % | 40 | 42 | 6.6 % | 7.0 % | 1.66 | — | 0.0 | 3.7 | — | — | — | -11.1 | — | 80.5 % | -121.2 % | -21.3 % | -11.3 % | — | — | -14.5 % | — | 0.0 % | 0.0 % | 7.9 | 68.0 % | 4.0 % | — |
| JFB JFB Construction Holdings Class A Common Stock | 08/13 | — | 75 6/21 | Stage 4 | D 44 | 4 of 9 | 0.1 $ | Real Estate - Development | – | — | — | Real Estate | 4.00 $ | -33.0 % | -33.5 % | +16.1 % | −86.2 % | +85.6 % | 40 | 7 | 8.8 % | 8.9 % | — | — | 0.0 | 2.3 | 1.3 | — | — | 204.3 | — | 8.0 % | -22.9 % | -29.9 % | -16.7 % | 0.04 | — | +6.7 % | — | 0.0 % | 0.0 % | 9.3 | 4.7 % | 1,230.8 % | — |
| RCKT Rocket Pharmaceuticals Inc | 08/06 | -28 % | 40 4/22 | Stage 4 | D 30 | 1 of 9 | 0.3 $ | Biotechnology | – | — | — | Healthcare | 3.10 $ | -1.1 % | -4.0 % | +2.0 % | −40.6 % | +202.8 % | 37 | 42 | 7.3 % | 6.4 % | 0.45 | — | 0.0 | — | — | — | — | 1.6 | — | — | 0.0 % | -64.4 % | -35.1 % | — | — | — | — | 0.0 % | 0.0 % | -10.4 | 89.9 % | 18.6 % | 4.6 (18) |
| PCT Purecycle Technologies Holdings Co | 08/06 | -4 % | 85 10/29 | Stage 4 | D 38 | 2 of 9 | 1.3 $ | Pollution & Treatment Controls | – | — | — | Industrials | 6.40 $ | -3.5 % | -17.9 % | -52.5 % | −54.5 % | +78.1 % | 34 | 42 | 7.1 % | 8.1 % | 2.51 | — | 142.9 | 119.4 | 175.4 | — | — | -11.0 | — | -970.5 % | 0.0 % | -80.9 % | -12.7 % | 99.53 | — | — | — | 0.0 % | 0.0 % | -0.6 | 69.1 % | 38.8 % | 4.0 (4) |
| NXB NextBoat Inc. | 08/13 | — | 50 2/11 | Stage 1 | D 34 | 2 of 9 | 0.1 $ | Auto & Truck Dealerships | – | — | — | Consumer Cyclical | 2.00 $ | — | — | — | −28.6 % | +367.3 % | 34 | 42 | 13.0 % | 10.4 % | — | — | 0.0 | 0.5 | — | — | — | 146.8 | — | 9.8 % | -4.6 % | -101.0 % | -4.1 % | — | — | +21.1 % | — | 0.0 % | 0.0 % | 3.1 | 1.1 % | 0.2 % | — |
| PESI Perma-Fix Environmental Svcs Inc | 08/06 | 0 % | 37 5/29 | Stage 4 | D 30 | 3 of 9 | 0.3 $ | Waste Management | Neutral | — | — | Industrials | 16.60 $ | -11.9 % | +3.6 % | +44.1 % | −25.8 % | +50.6 % | 34 | 15 | 7.2 % | 7.1 % | 0.45 | — | 99.0 | 5.9 | — | — | — | -31.4 | — | 4.1 % | -30.1 % | -28.5 % | -11.1 % | — | — | +4.3 % | — | 0.0 % | 0.0 % | -1.0 | 49.3 % | 11.7 % | 5.0 (1) |
| PRME Prime Medicine, Inc. Common Stock | 08/06 | -26 % | 56 5/22 | Stage 4 | D 34 | 1 of 9 | 0.5 $ | Biotechnology | – | — | — | Healthcare | 2.90 $ | -6.6 % | +4.2 % | -21.9 % | −54.2 % | +145.4 % | 32 | 42 | 10.1 % | 9.0 % | 2.27 | — | 0.0 | 136.5 | 7.4 | — | — | -3.1 | — | -3,722.0 % | 0.0 % | -216.1 % | -41.5 % | 1.49 | — | +55.3 % | — | 0.0 % | 0.0 % | -9.0 | 66.6 % | 23.8 % | 4.2 (12) |
| ASLE AerSale Corp | 08/05 | -19 % | 37 5/29 | Stage 4 | C 54 | 5 of 9 | 0.3 $ | Airports & Air Services | – | — | — | Industrials | 6.20 $ | -9.4 % | -11.8 % | +2.7 % | −29.3 % | +20.2 % | 31 | 88 | 4.3 % | 3.6 % | 0.27 | — | 8.1 | 0.8 | — | — | — | 12.2 | — | 31.4 % | 3.1 % | 2.5 % | 1.8 % | — | — | -2.8 % | — | 0.0 % | 0.0 % | 8.0 | 61.3 % | 4.1 % | — |
| ELWT Elauwit Connection, Inc. Common Stock | 08/13 | — | 94 10/24 | Stage 1 | D 36 | 3 of 9 | 0.1 $ | Telecom Services | – | — | — | Communication Services | 8.20 $ | +18.9 % | +30.7 % | — | −36.8 % | +95.4 % | 31 | 42 | 10.5 % | 10.2 % | — | — | 0.0 | 2.6 | 23.9 | — | — | 0.0 | — | 17.3 % | -28.9 % | 0.0 % | -35.6 % | 0.82 | — | +154.5 % | — | 0.0 % | 0.0 % | -4.6 | 8.6 % | 1.1 % | — |
| REZI Resideo Technologies Inc | 08/04 | +26 % | 9 2/29 | Stage 4 | D 42 | 5 of 9 | 5.2 $ | Industrial Distribution | – | — | — | Industrials | 34.30 $ | -13.0 % | -15.2 % | +25.6 % | −28.6 % | +43.8 % | 30 | 97 | 4.6 % | 4.7 % | 1.64 | — | 11.9 | 0.7 | 2.0 | — | — | 12.0 | 7.9 % | 29.4 % | -6.5 % | -15.8 % | 5.1 % | 1.20 | 35.6 % | +10.5 % | — | 0.0 % | 0.0 % | 5.1 | 99.1 % | 4.7 % | 3.5 (4) |
| CDZI Cadiz Inc | 08/12 | +1 % | 50 3/15 | Stage 4 | D 39 | 3 of 9 | 0.3 $ | Utilities - Regulated Water | – | — | — | Utilities | 3.00 $ | -27.5 % | -32.0 % | -6.0 % | −47.6 % | +219.6 % | 29 | 42 | 6.6 % | 6.7 % | 1.83 | — | 14.9 | 16.8 | — | — | 1.51 | -25.1 | — | 31.4 % | -221.4 % | -111.3 % | -10.7 % | — | — | +69.8 % | — | 0.0 % | 0.0 % | -12.9 | 48.8 % | 12.5 % | — |
| GANX Gain Therapeutics Inc | 08/11 | -20 % | 41 4/22 | Stage 4 | D 27 | 5 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 1.70 $ | -45.0 % | -38.5 % | +15.1 % | −60.4 % | +318.6 % | 29 | 42 | 6.7 % | 7.2 % | 0.16 | — | 0.0 | — | 5.2 | — | — | -1.5 | — | — | 0.0 % | -214.7 % | -81.2 % | 0.05 | — | -100.0 % | — | 0.0 % | 0.0 % | -14.5 | 19.2 % | 9.3 % | — |
| RWT Redwood Trust Inc | 07/29 | +3 % | 19 2/21 | Stage 1 | D 41 | 1 of 9 | 0.6 $ | REIT - Mortgage | – | — | — | Real Estate | 4.60 $ | -6.7 % | -5.9 % | -4.4 % | −32.1 % | +28.4 % | 28 | 14 | 3.2 % | 2.7 % | 1.43 | — | 5.9 | 0.5 | 0.7 | — | 1.47 | 0.0 | — | 80.9 % | 2.2 % | -8.6 % | 0.0 % | 26.42 | — | +356.5 % | — | 15.8 % | 78.3 % | 2.4 | 76.6 % | 0.0 % | 4.0 (8) |
| CMCO Columbus McKinnon Corporation | 07/29 | -21 % | 3 1/29 | Stage 4 | D 42 | 3 of 9 | 0.6 $ | Farm & Heavy Construction Machinery | – | — | — | Industrials | 19.20 $ | -18.0 % | -18.3 % | +33.1 % | −39.4 % | +34.1 % | 27 | 78 | 6.5 % | 6.5 % | 1.39 | — | 10.9 | 0.4 | — | — | 0.46 | 9.8 | — | 35.1 % | -21.3 % | -19.7 % | 2.6 % | — | — | +23.9 % | — | 1.5 % | 13.4 % | 4.6 | 100.3 % | 28.1 % | 4.0 (4) |
| CULP Culp, Inc. Common Stock | 07/01 | -11 % | 52 7/31 | Stage 4 | D 37 | 5 of 9 | 0.0 $ | Textile Manufacturing | – | — | — | Consumer Cyclical | 3.50 $ | -12.4 % | -8.0 % | -18.1 % | −35.6 % | +158.9 % | 26 | 11 | 5.1 % | 5.2 % | 1.21 | — | 10.6 | 0.2 | — | — | 0.59 | -57.4 | — | 12.4 % | -5.0 % | -18.3 % | -5.1 % | — | — | -5.4 % | — | 0.0 % | 0.0 % | 5.7 | 60.3 % | 0.3 % | — |
| FBRX Forte Biosciences Inc | 08/13 | -23 % | 82 7/22 | Stage 1 | D 30 | 3 of 9 | 0.4 $ | Biotechnology | – | — | — | Healthcare | 76.60 $ | -33.4 % | -22.3 % | +667.5 % | −47.7 % | -3.7 % | 26 | 42 | 7.7 % | 8.6 % | 2.84 | — | 0.0 | — | 10.2 | — | — | 1.9 | — | — | 0.0 % | -188.4 % | -83.9 % | — | — | -100.0 % | — | 0.0 % | 0.0 % | -10.3 | 74.8 % | 10.1 % | 5.0 (4) |
| MDAI Spectral AI Inc. | 08/11 | -28 % | 70 6/22 | Stage 3 | D 27 | 1 of 9 | 0.0 $ | Medical Devices | – | — | — | Healthcare | 1.60 $ | +20.4 % | +17.4 % | -37.5 % | −48.0 % | +224.4 % | 26 | 42 | 4.9 % | 7.9 % | 1.17 | — | 52.4 | 2.8 | — | — | — | -3.4 | — | 46.0 % | -82.0 % | -2,308.3 % | -31.5 % | — | — | -33.6 % | — | 0.0 % | 0.0 % | -14.9 | 15.2 % | 10.5 % | — |
| VANI Vivani Medical Inc. | 08/12 | -25 % | 71 6/22 | Stage 4 | D 30 | 5 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 1.30 $ | -3.3 % | -9.0 % | -4.5 % | −40.6 % | +236.3 % | 26 | 42 | 6.5 % | 5.4 % | 3.29 | — | 0.0 | — | — | — | — | -3.9 | — | — | 0.0 % | -176.4 % | -44.7 % | — | — | -100.0 % | — | 0.0 % | 0.0 % | -9.9 | 6.5 % | 0.9 % | — |
| LMNR Limoneira Co | — | -4 % | 91 6/16 | Stage 4 | D 27 | 2 of 9 | 0.2 $ | Farm Products | – | — | — | Consumer Defensive | 13.00 $ | +4.7 % | +2.1 % | -10.7 % | −23.6 % | +64.2 % | 25 | 85 | 3.4 % | 3.9 % | 0.29 | — | 14.5 | 1.8 | — | — | 5.92 | 41.9 | — | -8.8 % | -30.5 % | -23.3 % | -7.2 % | — | — | -16.6 % | — | 2.2 % | 69.8 % | 3.0 | 58.9 % | 4.8 % | — |
| RCEL Avita Medical Ltd | 08/06 | -25 % | 42 4/22 | Stage 1 | D 39 | 5 of 9 | 0.1 $ | Medical Devices | – | — | — | Healthcare | 4.40 $ | +13.6 % | +20.7 % | -17.0 % | −44.9 % | +130.2 % | 25 | 42 | 6.1 % | 7.4 % | 1.86 | — | 10.3 | 1.9 | — | — | — | -6.2 | — | 81.4 % | -62.7 % | -1,746.3 % | -40.8 % | — | — | +11.5 % | — | 0.0 % | 0.0 % | -33.3 | 17.2 % | 10.6 % | — |
| GALT Galectin Therapeutics Inc | 08/13 | +39 % | 41 4/22 | Stage 4 | D 31 | 5 of 9 | 0.2 $ | Biotechnology | – | — | — | Healthcare | 3.00 $ | -25.0 % | +23.3 % | -18.4 % | −40.7 % | +160.0 % | 25 | 42 | 14.5 % | 10.6 % | 0.35 | — | 4.5 | — | 147.3 | — | — | -4.0 | — | — | 0.0 % | -3,728.0 % | -80.4 % | -1.04 | — | — | — | 0.0 % | 0.0 % | -90.0 | 21.2 % | 18.7 % | — |
| SAFX XCF Global, Inc. Class A Common Stock | — | -33 % | 71 4/15 | Stage 3 | D 39 | 5 of 9 | 0.1 $ | Utilities - Renewable | – | — | — | Utilities | 0.36 $ | +67.3 % | -49.1 % | -74.3 % | −85.4 % | +111.5 % | 25 | 42 | 16.7 % | 14.6 % | -0.31 | 1.6 | 0.0 | — | 5.1 | — | — | 3.5 | — | -19.3 % | 300.8 % | 187.2 % | -8.6 % | 4.79 | — | — | — | 0.0 % | 0.0 % | -1.0 | 4.0 % | 4.9 % | — |
| CV CapsoVision, Inc. Common Stock | 08/13 | — | 82 7/22 | Stage 1 | D 38 | 5 of 9 | 0.3 $ | Medical Devices | – | — | — | Healthcare | 6.60 $ | -39.2 % | -45.7 % | +70.3 % | −54.5 % | +51.5 % | 24 | 42 | 7.0 % | 7.4 % | — | — | 0.0 | 24.8 | 16.3 | — | — | 0.0 | — | 51.7 % | -198.9 % | -185.1 % | -88.1 % | 0.04 | — | +15.3 % | — | 0.0 % | 0.0 % | -15.7 | 8.1 % | 5.6 % | — |
| PMT PennyMac Mortgage Investment Trust | 07/28 | +4 % | 44 4/21 | Stage 4 | C 50 | 4 of 9 | 0.8 $ | REIT - Mortgage | Uses AI | — | — | Real Estate | 9.40 $ | -17.2 % | -10.3 % | -8.3 % | −23.9 % | +26.5 % | 23 | 63 | 3.0 % | 2.6 % | 1.09 | — | 7.0 | 0.6 | — | — | 0.76 | 5.7 | — | 80.5 % | 27.6 % | 7.6 % | 0.8 % | — | — | +245.8 % | — | 17.0 % | 112.7 % | 1.4 | 79.7 % | 10.6 % | 3.2 (9) |
| ESLA Estrella Immunopharma Inc. | — | -32 % | 82 7/22 | Stage 4 | D 30 | 3 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 0.71 $ | -35.9 % | -35.2 % | -15.0 % | −69.8 % | +1,163.2 % | 23 | 42 | 8.2 % | 8.7 % | 0.86 | — | 0.0 | — | 3.1 | — | — | -3.1 | — | — | 0.0 % | -268.5 % | -271.5 % | — | — | — | — | 0.0 % | 0.0 % | -54.7 | 12.2 % | 0.7 % | — |
| FTCI FTC Solar Inc | 08/04 | -30 % | 62 6/25 | Stage 4 | C 53 | 4 of 9 | 0.0 $ | Solar | – | — | — | Technology | 2.80 $ | -52.2 % | -58.7 % | -51.8 % | −64.2 % | +124.8 % | 22 | 42 | 9.6 % | 9.9 % | 1.81 | — | 18.8 | 0.4 | 7.5 | — | — | -0.7 | — | 1.4 % | -44.9 % | -955.8 % | -25.3 % | -3.81 | — | +110.5 % | — | 0.0 % | 0.0 % | -10.6 | 10.1 % | 9.0 % | — |
| BMEA Biomea Fusion Inc | 08/04 | -32 % | 81 7/22 | Stage 4 | D 32 | 5 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 1.20 $ | -0.8 % | +7.8 % | -29.5 % | −58.9 % | +455.6 % | 21 | 42 | 6.6 % | 7.7 % | -0.33 | — | 0.0 | — | — | — | — | -3.8 | — | — | 0.0 % | -189.4 % | -79.3 % | — | — | — | — | 0.0 % | 0.0 % | -30.1 | 38.9 % | 23.6 % | — |
| BZAI Blaize Holdings, Inc. | 08/13 | -29 % | 35 4/25 | Stage 4 | C 54 | 6 of 9 | 0.1 $ | Software - Application | – | — | — | Technology | 0.79 $ | -24.1 % | -35.2 % | -79.7 % | −79.0 % | +238.0 % | 21 | 42 | 9.9 % | 10.8 % | 0.08 | — | 0.0 | 2.8 | 4.4 | — | — | 0.0 | — | 17.6 % | -202.7 % | -388.1 % | -65.2 % | 0.11 | — | +2,386.0 % | — | 0.0 % | 0.0 % | -19.8 | 34.7 % | 13.1 % | — |
| BRID Bridgford Foods Corporation | — | -14 % | 99 9/16 | Stage 4 | D 33 | 2 of 9 | 0.1 $ | Packaged Foods | – | — | — | Consumer Defensive | 6.40 $ | -13.8 % | -10.6 % | -16.6 % | −24.0 % | +19.4 % | 20 | 22 | 4.2 % | 3.9 % | -0.15 | — | 14.7 | 0.2 | — | — | 0.74 | 14.6 | — | 16.8 % | -6.1 % | -12.2 % | -8.7 % | — | — | +3.3 % | — | 0.0 % | 0.0 % | 9.7 | 5.5 % | 0.6 % | — |
| LUCD Lucid Diagnostics Inc | 08/12 | -8 % | 29 3/22 | Stage 4 | C 50 | 7 of 9 | 0.2 $ | Medical Devices | – | — | — | Healthcare | 0.87 $ | -5.5 % | -5.4 % | -10.9 % | −36.2 % | +279.8 % | 20 | 42 | 5.6 % | 6.1 % | 1.07 | — | 0.0 | 32.5 | — | — | — | -0.7 | — | -31.4 % | 0.0 % | -710.6 % | -92.1 % | — | — | +8.3 % | — | 0.0 % | 0.0 % | -33.6 | 19.4 % | 4.8 % | — |
| TVGN Tevogen Bio Holdings Inc. | 08/18 | -33 % | 58 5/22 | Stage 4 | E 19 | 4 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 7.10 $ | -42.5 % | -68.2 % | -85.7 % | −20.7 % | -79.0 % | 20 | 42 | 12.9 % | 16.1 % | 0.22 | — | 0.0 | — | 0.0 | — | — | 18.3 | — | — | 0.0 % | 0.0 % | -294.4 % | -0.31 | — | — | — | 0.0 % | 0.0 % | -129.5 | 3.6 % | 5.3 % | — |
| GNSS Genasys Inc | 08/13 | -13 % | 62 6/25 | Stage 4 | B 62 | 6 of 9 | 0.1 $ | Scientific & Technical Instruments | – | — | — | Technology | 1.70 $ | -23.1 % | -20.3 % | +3.7 % | −39.3 % | +194.7 % | 18 | 3 | 5.6 % | 5.5 % | 0.73 | — | 12.7 | 1.2 | 26.3 | — | — | 128.6 | — | 45.9 % | -13.4 % | -144.2 % | -6.3 % | 5.74 | — | +69.8 % | — | 0.0 % | 0.0 % | -5.6 | 58.0 % | 2.0 % | — |
| AMTX Aemetis Inc | 08/06 | -23 % | 66 6/23 | Stage 4 | C 47 | 5 of 9 | 0.1 $ | Specialty Chemicals | – | — | — | Basic Materials | 1.50 $ | +29.5 % | +22.5 % | -44.5 % | −57.6 % | +761.8 % | 17 | 42 | 7.9 % | 8.0 % | 1.44 | — | 58.8 | 0.5 | 131.8 | — | — | -8.8 | — | 3.2 % | -33.8 % | 0.0 % | -6.8 % | -1.26 | — | -22.3 % | — | 0.0 % | 0.0 % | -14.8 | 18.3 % | 7.9 % | — |
| BYSI BeyondSpring Inc | 08/12 | +11 % | 57 5/22 | Stage 4 | E 21 | 2 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 1.20 $ | -1.2 % | -6.8 % | -43.9 % | −38.9 % | -21.9 % | 17 | 42 | 5.5 % | 8.6 % | 0.43 | — | 10.5 | — | 4.0 | — | — | 0.0 | — | 72.0 % | 0.0 % | -310.5 % | -19.3 % | -0.01 | — | -100.0 % | — | 0.0 % | 0.0 % | -72.8 | 14.6 % | 6.5 % | — |
| STXS Stereotaxis Inc | 08/06 | +3 % | 7 1/22 | Stage 4 | D 44 | 5 of 9 | 0.1 $ | Medical Instruments & Supplies | – | — | — | Healthcare | 1.30 $ | -23.9 % | -28.8 % | -44.5 % | −54.9 % | +154.6 % | 17 | 42 | 6.2 % | 5.5 % | 1.34 | — | 19.6 | 4.0 | 9.2 | — | 1.31 | 151.4 | — | 53.9 % | -69.5 % | -156.1 % | -24.7 % | 0.27 | — | +20.3 % | — | 0.0 % | 0.0 % | -32.9 | 44.8 % | 4.7 % | — |
| EXOZ eXoZymes, Inc. | 08/11 | — | 82 7/22 | Stage 4 | E 14 | 2 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 4.70 $ | -29.4 % | -32.5 % | -54.0 % | −59.8 % | — | 16 | 42 | 12.9 % | 9.0 % | — | — | 0.0 | — | 28.0 | — | — | 0.0 | — | — | 0.0 % | -185.8 % | -81.6 % | 0.76 | — | — | — | 0.0 % | 0.0 % | -31.3 | 0.7 % | 0.3 % | — |
| HDSN Hudson Technologies Inc | 07/29 | -13 % | 22 3/23 | Stage 4 | D 41 | 4 of 9 | 0.2 $ | Specialty Chemicals | – | — | — | Basic Materials | 6.00 $ | -15.9 % | -21.3 % | -35.7 % | −47.1 % | +52.6 % | 15 | 5 | 3.9 % | 4.1 % | 0.78 | 18.7 | 14.3 | 1.0 | 1.1 | — | 0.39 | 10.3 | — | 24.6 % | 5.7 % | 5.9 % | 4.3 % | 0.02 | — | +4.0 % | — | 0.0 % | 0.0 % | 11.9 | 81.3 % | 4.0 % | — |
| ATHR Aether Holdings, Inc. | — | — | 81 8/25 | Stage 4 | D 36 | 4 of 9 | 0.0 $ | Software - Application | – | — | — | Technology | 3.30 $ | -48.4 % | -22.1 % | -65.4 % | −76.9 % | +131.9 % | 14 | 42 | 15.2 % | 10.7 % | — | — | 0.0 | 35.0 | — | — | — | 0.0 | — | 76.6 % | 0.0 % | -545.1 % | -183.5 % | — | — | -4.1 % | — | 0.0 % | 0.0 % | -10.9 | 1.0 % | 6.7 % | — |
| AGEN Agenus Inc | 08/10 | -30 % | 16 2/22 | Stage 4 | C 45 | 6 of 9 | 0.3 $ | Biotechnology | Neutral | — | Healthcare | 7.50 $ | -2.2 % | -6.0 % | +35.9 % | −60.8 % | +438.2 % | 13 | 42 | 7.3 % | 6.9 % | 1.55 | — | 1.6 | 2.6 | — | — | 1.44 | 1.2 | — | 97.4 % | 52.2 % | -1,278.8 % | 2.5 % | — | — | +10.4 % | — | 0.0 % | 0.0 % | -35.9 | 23.5 % | 11.6 % | — | |
| CBUS Cibus Global LLC | 08/13 | -30 % | 41 4/22 | Stage 4 | C 49 | 6 of 9 | 0.2 $ | Biotechnology | – | — | — | Healthcare | 1.90 $ | -21.3 % | -18.3 % | +30.4 % | −68.0 % | +994.5 % | 12 | 42 | 9.1 % | 8.5 % | 1.65 | — | 0.0 | 35.6 | 4.2 | — | — | -1.1 | — | 100.0 % | 0.0 % | -190.1 % | -11.2 % | 7.78 | — | -14.6 % | — | 0.0 % | 0.0 % | -6.5 | 33.6 % | 8.6 % | — |
| RNTX Rein Therapeutics Inc | 08/13 | -25 % | 58 5/22 | Stage 4 | D 30 | 2 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 0.74 $ | -16.5 % | -21.2 % | -36.7 % | −57.1 % | +751.1 % | 12 | 42 | 8.9 % | 8.4 % | 1.35 | — | 0.0 | — | — | — | — | -0.6 | — | — | 0.0 % | -163.4 % | -32.1 % | — | — | — | — | 0.0 % | 0.0 % | -60.0 | 24.6 % | 0.4 % | — |
| BRFH Barfresh Food Group Inc | 08/12 | +18 % | 71 4/15 | Stage 4 | B 61 | 3 of 9 | 0.0 $ | Beverages - Non-Alcoholic | – | — | — | Consumer Defensive | 1.70 $ | -31.7 % | -26.1 % | -46.8 % | −67.1 % | +162.5 % | 10 | 42 | 6.6 % | 5.8 % | 0.71 | — | 96.2 | 1.6 | 17.0 | — | — | -5.6 | — | 19.2 % | -15.3 % | -116.1 % | -16.1 % | 4.69 | — | +32.6 % | — | 0.0 % | 0.0 % | -12.6 | 22.3 % | 0.2 % | — |
Price Chart
Quarterly Figures
No quarterly data available.
Frequently Asked Questions
The mirror image of the Graham Net-Net shopping list: instead of companies with a bulging current-asset cushion, this scanner finds companies that are running out of cash. Criteria: the operating business is burning cash (operating cash flow over the trailing four quarters is negative in total), and cash plus short-term investments would last less than four quarters at the current burn rate.
All scanners are recalculated daily across the entire stock universe — most recently on 3. August 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).
Currently, 139 stocks pass this scanner's criteria (as of 3. August 2026). The 100 strongest hits are shown.
No global trading filters — this strategy checks the entire stock universe purely against its own criteria (mega caps over $50B included).
This scanner deliberately hunts for red flags — a hit is a finding, not a recommendation: like a smoke detector that beeps so you look in time. A hit is also not a bankruptcy verdict; most companies save themselves (say, through a capital raise, which dilutes existing shareholders). Portfolio owners use the list as an early-warning system, bargain hunters as an anti-shopping list, experienced traders as a watch list — it is never a buy or short recommendation.
Related scanners
- Altman Z: Distress Zone
- Bankruptcy Study: Stacked Warning Signals
- Below the 50- & 200-SMA
- Beneish M-Score
- Downward Momentum
- Going Concern (Distress Proxy)
- Kathy Donnelly: Liquid Movers Down
- Mike Webster: Overextended (Webby RSI)
- Near 52-Week Low
- Pradeep Bonde: $ Breakout Bearish
- Pradeep Bonde: 4% Breakout Bearish
- Qullamaggie: Parabolic (Short-Watch)
- RS Weakness (≤10)
- Stage 4 (Downtrend)
- Stan Weinstein: Stage 4
- Stan Weinstein: Stage 4B-
- Thomas Insolvency Candidate
- Weakness Cluster
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.